Katharina Balschun
Overview
Explore the profile of Katharina Balschun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmeti H, Balschun K, Mehdorn H, Stark A
J Neurooncol
. 2014 Jul;
119(2):447-8.
PMID: 25007775
No abstract available.
2.
von Schonfels W, von Kampen O, Patsenker E, Stickel F, Schniewind B, Hinz S, et al.
PLoS One
. 2013 Sep;
8(9):e72022.
PMID: 24058442
Background And Aims: High frequency electrosurgery has a key role in the broadening application of liver surgery. Its molecular signature, i.e. the metabolites evolving from electrocauterization which may inhibit hepatic...
3.
Warneke V, Behrens H, Haag J, Balschun K, Boger C, Becker T, et al.
Diagn Mol Pathol
. 2013 Jul;
22(3):127-37.
PMID: 23846438
We investigated various phenotypic and genotypic biomarkers of gastric cancer (GC) testing the following hypotheses: are these biomarkers suitable for the identification of GC subtypes, are they of prognostic significance,...
4.
Steffen J, Simon E, Warneke V, Balschun K, Ebert M, Rocken C
Virchows Arch
. 2012 Aug;
461(4):355-65.
PMID: 22855134
Gastric cancer (GC) is one of the most common causes of cancer-related deaths worldwide. We investigated the differential expression and putative tumor biological significance of five G-protein-coupled receptors (GPCRs) in...
5.
Bartel F, Balschun K, Gradhand E, Strauss H, Dittmer J, Hauptmann S
Int J Gynecol Pathol
. 2012 Jul;
31(5):405-15.
PMID: 22833079
Members of the CCN [cystein-rich 61 (Cyr61)/connective tissue growth factor (CTGF)/nephroblastoma (NOV)] protein family are involved in the regulation of cellular proliferation, apoptosis, and migration and are also assumed to...
6.
Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, et al.
Nat Med
. 2012 Jun;
18(7):1060-8.
PMID: 22706385
In most adult humans, hepatitis B is a self-limiting disease leading to life-long protective immunity, which is the consequence of a robust adaptive immune response occurring weeks after hepatitis B...
7.
Balschun K, Wenke A, Rocken C, Haag J
Expert Rev Mol Diagn
. 2011 Oct;
11(8):799-802.
PMID: 22022941
Evaluation of: Magnin S, Viel E, Baraquin A et al. A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers. J. Mol....
8.
Balschun K, Haag J, Wenke A, von Schonfels W, Schwarz N, Rocken C
J Mol Diagn
. 2011 Jun;
13(4):436-45.
PMID: 21704278
Targeted therapy of advanced colorectal carcinoma (CRC) necessitates KRAS genotyping. Because we were interested in diagnostic and therapeutic consequences, we studied the KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes...
9.
Ammerpohl O, Pratschke J, Schafmayer C, Haake A, Faber W, von Kampen O, et al.
Int J Cancer
. 2011 Apr;
130(6):1319-28.
PMID: 21500188
Abberrant DNA methylation is one of the hallmarks of cancerogenesis. Our study aims to delineate differential DNA methylation in cirrhosis and hepatic cancerogenesis. Patterns of methylation of 27,578 individual CpG...
10.
Wynendaele J, Bohnke A, Leucci E, Jensby Nielsen S, Lambertz I, Hammer S, et al.
Cancer Res
. 2010 Nov;
70(23):9641-9.
PMID: 21084273
Overexpression of MDM4 (also known as MDMX or HDMX) is thought to promote tumorigenesis by decreasing p53 tumor suppressor function. Even modest decrease in Mdm4 levels affects tumorigenesis in mice,...